AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3711368 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal psychotherapy
Number of subjects: 0
Study 29411112 — intervention group
Group type: EXPERIMENTAL
Intervention: xenogenic graft plus modified perforated collagen membrane (MPM)
Number of subjects: 15
Study 29411112 — intervention group
Group type: COMPARATOR
Intervention: xenogenic graft plus standard collagen membrane (CM)
Number of subjects: 15
Study 27221288 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated extinction
Number of subjects: 43
Study 27221288 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime fading
Number of subjects: 43
Study 27221288 — intervention group
Group type: COMPARATOR
Intervention: Sleep education control
Number of subjects: 43
Study 24986183 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) among older adults
Number of subjects: 0
Study 24986183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort-based ADL and IADL disparities
Number of subjects: 0
Study 20960029 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin with dexamethasone
Number of subjects: 41
Study 20960029 — intervention group
Group type: COMPARATOR
Intervention: Trabectedin with placebo
Number of subjects: 41
Study 21189693 — intervention group
Group type: EXPERIMENTAL
Intervention: Excellent glycemic control (HbA1c 6.74 +/- 0.16%)
Number of subjects: 30
Study 21189693 — intervention group
Group type: EXPERIMENTAL
Intervention: Fair glycemic control (HbA1c 8.45 +/- 0.30%)
Number of subjects: 30
Study 21189693 — intervention group
Group type: COMPARATOR
Intervention: Uncontrolled state (HbA1c 10.08 +/- 0.48%)
Number of subjects: 30
Study 18786230 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg teriparatide (PTH 1‐34) daily subcutaneous injections
Number of subjects: 26
Study 18786230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 16006746 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position during GMA recording
Number of subjects: 17
Study 16006746 — intervention group
Group type: COMPARATOR
Intervention: Recumbent position during GMA recording
Number of subjects: 17
Study 12439652 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care behavioral intervention
Number of subjects: 120
Study 12439652 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 120
Study 10366917 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA (84 hips)
Number of subjects: 155
Study 10366917 — intervention group
Group type: COMPARATOR
Intervention: Harris-Galante (87 hips)
Number of subjects: 155
Study 7673655 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 14
Study 7673655 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylscopolamine
Number of subjects: 14
Study 2143597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril alone (2.5-5 mg/day)
Number of subjects: 661
Study 2143597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 661
Study 2143597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg in combination with furosemide 20 mg
Number of subjects: 661
Study 2143597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during run-in period)
Number of subjects: 661
Study 6993652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 0
Study 6993652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31974670 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 70
Study 31974670 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (C)
Number of subjects: 70
Study 30782957 — intervention group
Group type: EXPERIMENTAL
Intervention: Revealed criteria for placental insufficiency
Number of subjects: 0
Study 30782957 — intervention group
Group type: COMPARATOR
Intervention: Concealed criteria for placental insufficiency
Number of subjects: 0
Study 30412115 — intervention group
Group type: EXPERIMENTAL
Intervention: In Plane (IP) technique
Number of subjects: 34
Study 30412115 — intervention group
Group type: COMPARATOR
Intervention: Out of Plane (OOP) technique
Number of subjects: 34
Study 30412115 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 34
Study 27178856 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard EEG assessment
Number of subjects: 73
Study 25143337 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (3 mg/kg per day for 8 weeks)
Number of subjects: 46
Study 25143337 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin (0.3-0.5 mg/kg per day for 8 weeks)
Number of subjects: 46
Study 25143337 — intervention group
Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 46
Study 22539829 — intervention group
Group type: EXPERIMENTAL
Intervention: Online postdilution hemodiafiltration (n=358)
Number of subjects: 714
Study 22539829 — intervention group
Group type: COMPARATOR
Intervention: Low-flux hemodialysis (n=356)
Number of subjects: 714
Study 18670465 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol maleate 0.5%
Number of subjects: 54
Study 18670465 — intervention group
Group type: EXPERIMENTAL
Intervention: brimonidine tartrate 0.2%
Number of subjects: 54
Study 18670465 — intervention group
Group type: EXPERIMENTAL
Intervention: travoprost 0.004%
Number of subjects: 54
Study 18670465 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 17045810 — intervention group
Group type: EXPERIMENTAL
Intervention: Form-related words
Number of subjects: 0
Study 17045810 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantically related words
Number of subjects: 0
Study 17045810 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 0
Study 15495698 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest as a therapy
Number of subjects: 0
Study 11239726 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) procedures providing incentives for specific behaviors
Number of subjects: 46
Study 11239726 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) procedures
Number of subjects: 46
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M0 patients
Number of subjects: 188
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M+ patients
Number of subjects: 188
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M1 patients
Number of subjects: 188
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M2 patients
Number of subjects: 188
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy regimen for M3 patients
Number of subjects: 188
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who failed treatment
Number of subjects: 188
Study 9231668 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 188
Study 8433239 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole cow milk (WCM)
Number of subjects: 104
Study 8433239 — intervention group
Group type: COMPARATOR
Intervention: Formula
Number of subjects: 104
Study 8433239 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled analysis of all feeding groups
Number of subjects: 104
Study 8433239 — intervention group
Group type: EXPERIMENTAL
Intervention: WCM
Number of subjects: 104
Study 8433239 — intervention group
Group type: EXPERIMENTAL
Intervention: WCM and Formula
Number of subjects: 104
Study 2821636 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive sponge
Number of subjects: 255
Study 2821636 — intervention group
Group type: COMPARATOR
Intervention: No sponge (Control)
Number of subjects: 255
Study 31415254 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized control trials
Number of subjects: 131
Study 29561278 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation (LPV group) [tidal volume 5 ml/kg ideal body weight + PEEP between 5 and 8 cmH2O]
Number of subjects: 346
Study 29561278 — intervention group
Group type: COMPARATOR
Intervention: Nonprotective ventilation (control group) [tidal volume 10 ml/kg ideal body weight without PEEP]
Number of subjects: 346
Study 29561278 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation (LPV group)
Number of subjects: 346
Study 29561278 — intervention group
Group type: COMPARATOR
Intervention: Nonprotective ventilation (control group)
Number of subjects: 346
Study 27108261 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior decompression, bone cement augmentation and internal fixation (n=14)
Number of subjects: 28
Study 27108261 — intervention group
Group type: COMPARATOR
Intervention: Only posterior decompression combined with internal fixation (n=14)
Number of subjects: 28
Study 27108261 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 28
Study 27108261 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (n=14)
Number of subjects: 28
Study 24346151 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 31
Study 24346151 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound therapy
Number of subjects: 31
Study 22692326 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced image group (n=30)
Number of subjects: 60
Study 22692326 — intervention group
Group type: COMPARATOR
Intervention: Common image group (n=30)
Number of subjects: 60
Study 20883734 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation-intention group
Number of subjects: 57
Study 20883734 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study 17525884 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (E) - home-based walking program, aerobic walking at target heart rate for 20 minutes or more daily, 2 or more days a week
Number of subjects: 200
Study 17525884 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) - normal level of activity
Number of subjects: 200
Study 17525884 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (E) - home-based walking program
Number of subjects: 200
Study 16084884 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic electrocautery of the ovaries
Number of subjects: 32
Study 16084884 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction with recombinant FSH (rFSH)
Number of subjects: 32
Study 16084884 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) treatment
Number of subjects: 32
Study 12100806 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy (six weekly instructional sessions on bladder training and individualized voiding schedules)
Number of subjects: 152
Study 12100806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instruction, kept urinary diaries for 6 weeks)
Number of subjects: 152
Study 12100806 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy (after 6 weeks for all women)
Number of subjects: 152
Study 10344481 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer applied on one arm/hand 3x daily for 9 days
Number of subjects: 12
Study 10344481 — intervention group
Group type: COMPARATOR
Intervention: Untreated control on the other arm/hand
Number of subjects: 12
Study 8744965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentional learning encoding
Number of subjects: 0
Study 8744965 — intervention group
Group type: EXPERIMENTAL
Intervention: Generating responses during intentional encoding
Number of subjects: 0
Study 8744965 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregate item JOLs
Number of subjects: 0
Study 1851692 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 12
Study 1851692 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 12
Study 7316527 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily ultraviolet radiation treatment with coal tar
Number of subjects: 9
Study 7316527 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily ultraviolet radiation treatment with coal tar
Number of subjects: 9
Study 31006575 — intervention group
Group type: COMPARATOR
Intervention: Annual school-based treatment with albendazole
Number of subjects: 150000
Study 31006575 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual community-wide treatment with albendazole
Number of subjects: 150000
Study 31006575 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual community-wide treatment with albendazole
Number of subjects: 150000
Study 27810407 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous PV catheter with a continuous infusion of 0.2% ropivacaine
Number of subjects: 48
Study 27810407 — intervention group
Group type: COMPARATOR
Intervention: Single-shot intercostal blocks (ICB)
Number of subjects: 48
Study 27810407 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous PV catheter
Number of subjects: 48
Study 25828982 — intervention group
Group type: EXPERIMENTAL
Intervention: Aftercare services (treatment follow-up, family psychoeducation, patient social skills training)
Number of subjects: 120
Study 25828982 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 120
Study 24521524 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse
Number of subjects: 280
Study 24521524 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood physical abuse
Number of subjects: 280
Study 24521524 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood emotional abuse
Number of subjects: 280
Study 21930734 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate monotherapy (target dose 20 mg/week)
Number of subjects: 147
Study 19923530 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (0, 5, 10, or 15 mg)
Number of subjects: 28
Study 19923530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 17322146 — intervention group
Group type: EXPERIMENTAL
Intervention: FBT 400 microg (transmucosal)
Number of subjects: 26
Study 17322146 — intervention group
Group type: EXPERIMENTAL
Intervention: FBT 800 microg (oral)
Number of subjects: 26
Study 17322146 — intervention group
Group type: EXPERIMENTAL
Intervention: OTFC 800 microg (transmucosal)
Number of subjects: 26
Study 17322146 — intervention group
Group type: COMPARATOR
Intervention: FBT compared to OTFC
Number of subjects: 26
Study 15223196 — intervention group
Group type: EXPERIMENTAL
Intervention: Damage to the superior colliculus contralateral to the cortical lesion
Number of subjects: 1
Study 15223196 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional damage to right superior colliculus
Number of subjects: 1
Study 15223196 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced right tecto-pulvinar activity
Number of subjects: 1
Study 11578785 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat combined with hypocaloric diet and moderate physical exercise
Number of subjects: 3305
Study 11578785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3305
Study 9608291 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic substitute for fluphenazine decanoate
Number of subjects: 0
Study 9608291 — intervention group
Group type: COMPARATOR
Intervention: Original product of fluphenazine decanoate
Number of subjects: 0
Study 7982862 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention program for sleep disturbances
Number of subjects: 28
Study 7982862 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 28
Study 2863289 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg
Number of subjects: 12
Study 2863289 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 400 mg
Number of subjects: 12
Study 2863289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2863289 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 12
Study 2863289 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (0.5 mg)
Number of subjects: 12
Study 30021540 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for adolescents (Op Koers Online)
Number of subjects: 0
Study 30021540 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for parents (Op Koers Online)
Number of subjects: 0
Study 30021540 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 30021540 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for adolescents
Number of subjects: 0
Study 30021540 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral based online group intervention for parents
Number of subjects: 0
Study 27539168 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives (up to $1,650) for biochemically verified abstinence at 1, 2, and 3 weeks, and 1, 3, and 6 months.
Number of subjects: 805
Study 27539168 — intervention group
Group type: COMPARATOR
Intervention: Booklets plus access to a smoking cessation website (control group).
Number of subjects: 805
Study 24559814 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Trikatu preparation
Number of subjects: 30
Study 24559814 — intervention group
Group type: COMPARATOR
Intervention: Reference product (camphor, menthol, eucalyptus)
Number of subjects: 30
Study 23061989 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin + metformin
Number of subjects: 178
Study 23061989 — intervention group
Group type: COMPARATOR
Intervention: Placebo + metformin
Number of subjects: 178
Study 19728035 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estrogen patch 0.1 mg
Number of subjects: 0
Study 19728035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19728035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day to 100 mg/day for 9 weeks
Number of subjects: 0
Study 18023899 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational atherectomy
Number of subjects: 266
Study 18023899 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 266
Study 18023899 — intervention group
Group type: COMPARATOR
Intervention: Non-debulking (rotational)
Number of subjects: 266
Study 18023899 — intervention group
Group type: COMPARATOR
Intervention: Non-debulking (directional)
Number of subjects: 266
Study 18023899 — intervention group
Group type: EXPERIMENTAL
Intervention: Debulking (combined)
Number of subjects: 266
Study 18023899 — intervention group
Group type: COMPARATOR
Intervention: Non-debulking (combined)
Number of subjects: 266
Study 17664519 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (cognitive-behavioral therapy and pharmacological management)
Number of subjects: 206
Study 17664519 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 206
Study 17664519 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (Control)
Number of subjects: 206
Study 14967388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 56
Study 14967388 — intervention group
Group type: COMPARATOR
Intervention: Fallopian tube sperm perfusion (FSP)
Number of subjects: 56
Study 10914616 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone extract (50 mg genistin and daidzin per day)
Number of subjects: 177
Study 10914616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 9180289 — intervention group
Group type: EXPERIMENTAL
Intervention: low-dose Ara-C with growth factors
Number of subjects: 45
Study 9180289 — intervention group
Group type: COMPARATOR
Intervention: low-dose Ara-C without growth factors
Number of subjects: 45
Study 9180289 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without clonal markers at diagnosis
Number of subjects: 45
Study 1564502 — intervention group
Group type: EXPERIMENTAL
Intervention: New intervention
Number of subjects: 0
Study 1564502 — intervention group
Group type: COMPARATOR
Intervention: Old intervention
Number of subjects: 0
Study 2436505 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 0
Study 2436505 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxamethonium
Number of subjects: 0
Study 2436505 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcuronium
Number of subjects: 0
Study 2436505 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 2436505 — intervention group
Group type: EXPERIMENTAL
Intervention: D-tubocurarine
Number of subjects: 0
Study 2436505 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 0
Study 31630990 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted inactivated vaccine
Number of subjects: 65
Study 31630990 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccine regimens
Number of subjects: 65
Study 31630990 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular study product or placebo
Number of subjects: 65
Study 31630990 — intervention group
Group type: COMPARATOR
Intervention: Intranasal study product or placebo
Number of subjects: 65
Study 31630990 — intervention group
Group type: COMPARATOR
Intervention: Study product or placebo
Number of subjects: 65
Study 31198066 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week mindfulness intervention
Number of subjects: 36
Study 31198066 — intervention group
Group type: COMPARATOR
Intervention: Breathing control
Number of subjects: 36
Study 28365035 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 210
Study 28365035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 27009046 — intervention group
Group type: EXPERIMENTAL
Intervention: Morita Therapy plus treatment as usual
Number of subjects: 60
Study 27009046 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 60
Study 24311443 — intervention group
Group type: EXPERIMENTAL
Intervention: HT (conjugated estrogens, 0.625 mg/d)
Number of subjects: 119
Study 24311443 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 119
Study 24311443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119